Plus Therapeutics (PSTV)

• Market cap: $74M
• 1 day: 4.73%
• 5 days: -1.68%
• 1 month: -34.47%
• 3 months: -29.09%
• 6 months: -4.52%
• Year to date: -54.4%
• 1 year: -60.43%
• 5 years: -98.32%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Employees: 21